CD62L expression was positively correlated with MELD score in both HCV and NAFLD cohorts (r = 0.51 P = 0.002 and r = 0.4 P = 0.02, respectively). This evidence concerns the gene SELL and metabolic dysfunction-associated steatotic liver disease.